Publications from the EBV-MS project

• New EBV-MS Video Highlights Groundbreaking Research and Human Stories Behind the Science Link here
• EBV-MS highlighted at MENACTRIMS 2025  Link here
• Advancing Multiple Sclerosis Research: Highlights from the Neuro-SysMed Symposium 2025 Link here
• EBV-MS Annual Consortium Meeting 2025: Strengthening Collaboration Towards Prevention and Understanding of Multiple Sclerosis  Link here
• EBV-MS Consortium at the European Charcot Foundation Link here
• Unraveling the EBV-MS Connection: Professor Øivind Torkildsen at MENACTRIMS 2025 Link here
• The EBV-MS Team Presents Groundbreaking Research at ISNI 2025 in Japan Link here  
• EBV-MS Consortium Showcases Cutting-Edge Research on Epstein-Barr Virus and Multiple Sclerosis at ECTRIMS 2025 Link here 
• Breaking Ground on EBV and MS: Highlights from ECTRIMS 2025 Educational Session Link here
• Meet Our new EBV-MS Partner: The Cyprus Institute of Neurology and Genetics (CING) Link here  
• Meeting with the Scientific Advisory Board of the EBV-MS Project Link here  
• Nobel Symposium on Multiple Sclerosis Highlights EBV Link Link here  
• On the role of EBV in MS - Educational Session at ECTRIMS 2025 Link here  
• Epstein-Barr Virus and It`s role in Multiple Sclerosis: A Growing Area of Research Link here  

• Research Data Management in EBV-MS Link here

   

• The EBV-MS Annual Consortium Meeting 2024: Reflecting on Progress Link here  
• ECTRIMS 2024 Link here 
• Engaging Expert Patients: MS CAB and EBV-MS Project Team Collaborate on Clinical Trial Design Link here 

• How Current Research Shapes the Future of MS Care: A Recap of Our Successful Symposium Link here

   

Fråga doktorn: Vaccin mot MS? SVT Februar 2026

En viss typ av korsreaktiva immunceller är vanligare hos patienter med multipel skleros (ms) än hos friska kontroller. Fyndet kan förklara varför infektion med Epstein-Barr-virus är nödvändigt för att ms ska uppstå. Dagens Medicin, Januar 2026

For 30 år siden fantes ingen behandling for sykdommen Sara Louise fikk som 17-åring - Newspaper BA ^{_{Feb 2025}}

Nytt forskningsprosjekt om kyssesykevirus og MS - Novartins Medhub _{^{Aug 2025}}

Investigating the Cause of Multiple Sclerosis - ft. Dr. Marianna Cortese - Podcast in Offspring Magazine _{^{Feb 2025}}

EBV-MS: Unveiling the relationship between Epstein-Barr virus and multiple sclerosis - el-lipse _{^{April 2025}}

The new Honorary Doctor hopes to create a vaccine against MS - UiB _{^{Aug 2025}}

How Does EBV Cause MS -- Hit and Run or Chronic Driver? ^{Nov 2025}

Studie: Oppsiktsvekkende om MS-medisin - Newspaper Dagbladet _{^{Jan 2025}}

Kan hiv-medisin hjelpe mot MS? - Forskning.no _{^{Feb 2024}}

MS i Norge - Sykdommen, årsakene og dagens og fremtidens behandling - YouTube _²⁰²⁴

Gir nytt håp til MS-syke - Magazine KK _{^{April 2024}}

MS: Et av verdens vanligste virus kan gi svar på gåten bak den nevrologiske sykdommen - HealthTalk _{^{March 2024}}

Kan HIV-medisin virke på MS-pasienter? Norske forskere vil finne det ut - Health Talk _{^{Oct 2024}}

Case Study Reports Positive Impact of Antiviral Therapy Tenofovir in MS, Warranting Further Research - NeurologyLive _{^{Feb 2024}}

Scientists want to tackle multiple sclerosis by treating the kissing virus - The Economist _{^{Feb 2024}}

5 quick questions about Epstein-Barr-virus and Multiple Sclerosis -UiB _{^{May 2024}}

Epstein-Barr virus: how does a common infection trick the immune system into attacking the brain in people with MS? - The Conversation _{^{June 2024}}

Risikoen for å få MS økte med 32 ganger etter en EBV-infeksjon - Nevrologisk Tidsskrift Aug 2023

Leder internasjonalt forskningsprosjekt: – Vi er nærmere en løsning på MS-gåten enn noen gang - Dagens Medisin _{^{Sept 2023}}

Norske forskere leder EU-prosjekt om MS og kyssesykevirus - MEDWATCH Sept 2023

Fantastisk forskningsmiddel-dryss over MS-feltet - Dagens Medisin _{^{Des 2023}}

Trekker frem en nedtur og to oppturer på MS-feltet i 2023 - Dagens Medisin _{^{Des 2023}}

Targeting Epstein-Barr virus to treat and prevent MS - UiB _{^{Sept 2023}}